Such sample sizes make feasible the use of such CBF measurements in clinical trials of drugs.
Such sample sizes are comparable to many existing genome-wide association studies, so they are well within reach.
Such sample sizes will be difficult to achieve for a rare disease like acute hepatitis C. Descriptive studies like this one may therefore be useful in making educated guesses for patient management until the results of randomized trials are available.
Such sample variation may influence the results.
Such sample sizes limit statistical analysis and the wider application of findings to the broader community.
Such sample documents can, for instance, be a set resulting from a search query over a large repository by using a series of search strings.
Such sample mix-ups can be a problem in any genetic study, but eQTL data allow us to identify, and even correct, such problems.
Such sample bias would negate any meaningful conclusions being drawn from subanalysis based on the location of neoplastic lesions and so such an analysis was not undertaken.
Such sample collection is usually relatively benign, painless and may not require any additional procedures other than what is clinically required.
Such sample preparation allowed us to avoid the use of fixative media and paraffin having IR spectral signatures that can mask absorption bands of biological components [ 21].
Such sample analysis also requires careful consideration of methods used, as facture healing results in a heterogeneous distribution of tissue, and therefore standardization of positions of sections and tissue samples should be evaluated and tracked carefully.
